"Das Zentralinstitut für Seelische Gesundheit steht für international herausragende Forschung und wegweisende Behandlungskonzepte in Psychiatrie und Psychotherapie, Kinder- und Jugendpsychiatrie, Psychosomatik und Suchtmedizin."

During the past decade, Central Institute of Mental Health conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Central Institute of Mental Health" #1 sponsor was "Central Institute of Mental Health, Mannheim" with 22 trials, followed by "Anavex Life Sciences Corp." with 2 trials sponsored, "Charite University, Berlin, Germany" with 1 trials sponsored, "Christian Paret" with 1 trials sponsored and "Prof Herta Flor" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Central Institute of Mental Health" #1 collaborator was "German Research Foundation" with 3 trials as a collaborator, "Anavex Australia Pty Ltd." with 2 trials as a collaborator, "Anavex Germany GmbH" with 2 trials as a collaborator, "German Federal Ministry of Education and Research" with 2 trials as a collaborator and "Heidelberg University" with 2 trials as a collaborator. Other collaborators include 17 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "Central Institute of Mental Health" are "Schizophrenia" (7 trials), "Alzheimer Disease" (2 trials), "Borderline Personality Disorder" (2 trials), "Healthy Volunteers" (2 trials) and "Modeling Psychosis" (2 trials). Many other conditions were trialed in "Central Institute of Mental Health" in a lesser frequency.

Most popular intervention types in "Central Institute of Mental Health" are "Drug" (17 trials), "Behavioral" (7 trials), "Other" (4 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Cannabidiol" (5 trials), "Olanzapine" (3 trials), "placebo" (3 trials) and "Amisulpride" (2 trials). Other intervention names were less common.

The vast majority of trials in "Central Institute of Mental Health" are 20 trials for "All" genders, 6 trials for "Male" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Central Institute of Mental Health". 1 are not yet recruiting, 5 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Central Institute of Mental Health, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Central Institute of Mental Health, 4 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 12 trials that are defined as “Not Applicable".